Incyte (INCY) News Today $70.07 +0.18 (+0.26%) Closing price 04:00 PM EasternExtended Trading$69.44 -0.63 (-0.89%) As of 05:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INCY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period MacroGenics stock soars on royalty deal with SagardJune 10 at 7:49 AM | investing.comPallas Capital Advisors LLC Raises Holdings in Incyte Co. (NASDAQ:INCY)Pallas Capital Advisors LLC raised its holdings in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 200.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 43,766 shares of the biopharmaceutical company's stock afterJune 10 at 5:51 AM | marketbeat.comGateway Investment Advisers LLC Increases Position in Incyte Co. (NASDAQ:INCY)Gateway Investment Advisers LLC lifted its position in Incyte Co. (NASDAQ:INCY - Free Report) by 95.4% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,828 shares of the biopharmaceutiJune 10 at 4:18 AM | marketbeat.comMillington Financial Advisors LLC Takes Position in Incyte Co. (NASDAQ:INCY)Millington Financial Advisors LLC bought a new stake in Incyte Co. (NASDAQ:INCY - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 25,127 shares of the biopharmaceutical company's stock, valued at approximaJune 9 at 8:01 AM | marketbeat.com4,871 Shares in Incyte Co. (NASDAQ:INCY) Purchased by Sivia Capital Partners LLCSivia Capital Partners LLC purchased a new position in Incyte Co. (NASDAQ:INCY - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 4,871 shares of the biopharmaceutical company's stock, valued at approximately $295,00June 9 at 4:59 AM | marketbeat.comIncyte Co. (NASDAQ:INCY) Shares Bought by Rhumbline AdvisersRhumbline Advisers lifted its holdings in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 10.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 337,103 shares of the biopharmaceutical company's stock afJune 7 at 4:10 AM | marketbeat.comIncyte’s Promising Pipeline and Strategic Developments Drive Buy Rating with $89 Price TargetJune 6, 2025 | tipranks.comIncyte Co. (NASDAQ:INCY) Shares Acquired by Merit Financial Group LLCMerit Financial Group LLC boosted its stake in Incyte Co. (NASDAQ:INCY - Free Report) by 305.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,611 shares of the biopharmaceutical company'sJune 6, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Acquires 36,351 Shares of Incyte Co. (NASDAQ:INCY)Wealth Enhancement Advisory Services LLC increased its holdings in Incyte Co. (NASDAQ:INCY - Free Report) by 315.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,884 shares of the biopharmaceuticJune 5, 2025 | marketbeat.comUBS Group Reiterates "Neutral" Rating for Incyte (NASDAQ:INCY)June 5, 2025 | americanbankingnews.comUS High Growth Tech Stocks To Watch In June 2025June 4, 2025 | finance.yahoo.comIncyte (NASDAQ:INCY) Trading Up 7.1% - Here's WhyIncyte (NASDAQ:INCY) Shares Up 7.1% - Here's WhyJune 4, 2025 | marketbeat.comIncyte stock rises following EHA presentation acceptanceJune 4, 2025 | investing.com3INCY : Where Incyte Stands With AnalystsJune 4, 2025 | benzinga.comIncyte Shares Jump After EHA Conference Accepts Key Research PresentationsJune 4, 2025 | msn.comIncyte’s mCALR Program: Promising Early Data but Uncertainties Remain, Justifying Hold RatingJune 4, 2025 | tipranks.comFulton Bank N.A. Reduces Stock Position in Incyte Co. (NASDAQ:INCY)Fulton Bank N.A. trimmed its holdings in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 16.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,158 shares of the biopharmaceutical company's stock afterJune 4, 2025 | marketbeat.comIncyte’s CAO Makes a Significant Stock Sale!June 3, 2025 | tipranks.comIncyte rises as it will present new data on thrombocythemia asset at conferenceJune 3, 2025 | seekingalpha.comIncyte’s Promising Clinical Trial Results and Favorable Safety Profile Drive Buy Rating with 34.7% Upside PotentialJune 3, 2025 | tipranks.comUBS Group Reaffirms "Neutral" Rating for Incyte (NASDAQ:INCY)UBS Group restated a "neutral" rating and set a $61.00 price objective on shares of Incyte in a research report on Tuesday.June 3, 2025 | marketbeat.comFilmmaker turns lens on his own cancer journey with his doctorJune 3, 2025 | usatoday.comWellington Management Group LLP Has $9.42 Million Holdings in Incyte Co. (NASDAQ:INCY)Wellington Management Group LLP boosted its stake in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 90.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 136,362 shares of the biopharmaceutical companyJune 3, 2025 | marketbeat.comRep. Robert Bresnahan, Jr. Sells Off Shares of Incyte Co. (NASDAQ:INCY)Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of Incyte Co. (NASDAQ:INCY). In a filing disclosed on May 31st, the Representative disclosed that they had sold between $1,001 and $15,000 in Incyte stock on May 15th. The trade occurred in the Representative's "JP MORGAN BRJune 3, 2025 | marketbeat.comIncyte Co. (NASDAQ:INCY) Short Interest Up 47.7% in MayIncyte Co. (NASDAQ:INCY - Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 9,470,000 shares, a growth of 47.7% from the April 30th total of 6,410,000 shares. Based on an average daily trading volume, of 2,000,000 shares, the days-to-cover ratio is presently 4.7 days. Currently, 5.0% of the company's stock are sold short.June 2, 2025 | marketbeat.comGAMMA Investing LLC Increases Stake in Incyte Co. (NASDAQ:INCY)GAMMA Investing LLC increased its holdings in Incyte Co. (NASDAQ:INCY - Free Report) by 5,849.9% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 342,955 shares of the biopharmaceutical company's stock after purchasing an additional 337,1June 2, 2025 | marketbeat.comAdvisory Alpha LLC Trims Stock Holdings in Incyte Co. (NASDAQ:INCY)Advisory Alpha LLC lowered its holdings in Incyte Co. (NASDAQ:INCY - Free Report) by 50.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,895 shares of the biopharmaceutical company's stock after selling 3,995 shares during the period. Advisory AlpJune 2, 2025 | marketbeat.comIncyte Co. (NASDAQ:INCY) Shares Acquired by Two Sigma Investments LPTwo Sigma Investments LP increased its position in Incyte Co. (NASDAQ:INCY - Free Report) by 36.3% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 28,049 shares of the biopharmaceutical company's stock after purchasing an additional 7,4June 2, 2025 | marketbeat.com53,291 Shares in Incyte Co. (NASDAQ:INCY) Purchased by Summit Global InvestmentsSummit Global Investments bought a new stake in Incyte Co. (NASDAQ:INCY - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 53,291 shares of the biopharmaceutical company's stock, valued at approxMay 31, 2025 | marketbeat.comSiemens Fonds Invest GmbH Invests $401,000 in Incyte Co. (NASDAQ:INCY)Siemens Fonds Invest GmbH bought a new stake in Incyte Co. (NASDAQ:INCY - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 5,806 shares of the biopharmaceutical cMay 31, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Takes Position in Incyte Co. (NASDAQ:INCY)Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Incyte Co. (NASDAQ:INCY - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 225,103 shares of the biopharmaceutical company's stock, valued at approMay 31, 2025 | marketbeat.comCentre Asset Management LLC Cuts Holdings in Incyte Co. (NASDAQ:INCY)Centre Asset Management LLC cut its position in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 6.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 127,167 shares of the biopharmaceutical company's stock after selling 8,987 shareMay 30, 2025 | marketbeat.comLansforsakringar Fondforvaltning AB publ Makes New Investment in Incyte Co. (NASDAQ:INCY)Lansforsakringar Fondforvaltning AB publ acquired a new position in shares of Incyte Co. (NASDAQ:INCY - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 56,738 shares of the biopharmaceutical company's stockMay 30, 2025 | marketbeat.comDelveInsight Business Research, LLP: Anal Cancer Market Heats Up Following Incyte's Zynyz Greenlight | DelveInsightMay 29, 2025 | finanznachrichten.deAnal Cancer Market Heats Up Following Incyte's Zynyz Greenlight | DelveInsightMay 29, 2025 | finance.yahoo.comIncyte: Good Company, But Potentially Overvalued Given Patent CliffsMay 29, 2025 | seekingalpha.comTruist Financial Issues Positive Forecast for Incyte (NASDAQ:INCY) Stock PriceTruist Financial upped their price target on shares of Incyte from $72.00 to $73.00 and gave the stock a "hold" rating in a research report on Tuesday.May 28, 2025 | marketbeat.com42,777 Shares in Incyte Co. (NASDAQ:INCY) Bought by Jefferies Financial Group Inc.Jefferies Financial Group Inc. acquired a new position in shares of Incyte Co. (NASDAQ:INCY - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 42,777 shares of the biophMay 28, 2025 | marketbeat.comMackenzie Financial Corp Sells 18,038 Shares of Incyte Co. (NASDAQ:INCY)Mackenzie Financial Corp lowered its position in Incyte Co. (NASDAQ:INCY - Free Report) by 6.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 242,035 shares of the biopharmaceutical comMay 28, 2025 | marketbeat.comRoyal Bank of Canada Buys 41,071 Shares of Incyte Co. (NASDAQ:INCY)Royal Bank of Canada raised its stake in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 24.4% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 209,479 shares of the biopharmaceutical company's stock after purchasing an adMay 28, 2025 | marketbeat.comIncyte to Present at Upcoming Investor ConferenceMay 27, 2025 | businesswire.comGF Fund Management CO. LTD. Takes Position in Incyte Co. (NASDAQ:INCY)GF Fund Management CO. LTD. purchased a new position in shares of Incyte Co. (NASDAQ:INCY - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 7,958 shares of the biopharmaceutical company's stock, valued at approMay 27, 2025 | marketbeat.comVoloridge Investment Management LLC Has $8.45 Million Holdings in Incyte Co. (NASDAQ:INCY)Voloridge Investment Management LLC cut its position in Incyte Co. (NASDAQ:INCY - Free Report) by 83.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 122,334 shares of the biopharmaceutical company's sMay 27, 2025 | marketbeat.comPeak Retirement Planning Inc. Takes Position in Incyte Co. (NASDAQ:INCY)Peak Retirement Planning Inc. purchased a new position in shares of Incyte Co. (NASDAQ:INCY - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 13,638 shares ofMay 26, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Holdings in Incyte Co. (NASDAQ:INCY)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Incyte Co. (NASDAQ:INCY - Free Report) by 11.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 1,536,238 shares of the biopharmaceutical company's stock after acquirMay 26, 2025 | marketbeat.comSquarepoint Ops LLC Acquires 83,291 Shares of Incyte Co. (NASDAQ:INCY)Squarepoint Ops LLC raised its holdings in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 326.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 108,835 shares of the biopharmaceutical company's stock afteMay 26, 2025 | marketbeat.com9,940 Shares in Incyte Co. (NASDAQ:INCY) Bought by Css LLC IlCss LLC Il bought a new position in shares of Incyte Co. (NASDAQ:INCY - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 9,940 shares of the biopharmaceutical company's stock, valued at approximately $687,000. Other hedgeMay 24, 2025 | marketbeat.comThe Best Places for Seniors to Work in RetirementMay 23, 2025 | money.usnews.comToronto Dominion Bank Acquires 102,152 Shares of Incyte Co. (NASDAQ:INCY)Toronto Dominion Bank raised its holdings in Incyte Co. (NASDAQ:INCY - Free Report) by 188.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 156,236 shares of the biopharmaceutical company's stock after buying an additional 10May 23, 2025 | marketbeat.comProShare Advisors LLC Reduces Stock Holdings in Incyte Co. (NASDAQ:INCY)ProShare Advisors LLC decreased its position in Incyte Co. (NASDAQ:INCY - Free Report) by 23.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 42,195 shares of the biopharmaceutical company's stock after sMay 23, 2025 | marketbeat.com Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Email Address INCY Media Mentions By Week INCY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INCY News Sentiment▼1.020.68▲Average Medical News Sentiment INCY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INCY Articles This Week▼1916▲INCY Articles Average Week Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alnylam Pharmaceuticals News Today Biogen News Today United Therapeutics News Today Neurocrine Biosciences News Today Exelixis News Today BioMarin Pharmaceutical News Today Exact Sciences News Today Repligen News Today Halozyme Therapeutics News Today Madrigal Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INCY) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored50-year legend: Here’s exact day stocks will crashGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incyte Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Incyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INCY Stock Free INCY Stock Alerts